Amneal Begin Period Cash Flow from 2010 to 2025
| AMRX Stock | USD 8.27 0.09 1.08% |
Begin Period Cash Flow | First Reported 2016-12-31 | Previous Quarter 49.6 M | Current Value 78.3 M | Quarterly Volatility 118.5 M |
Check Amneal Pharmaceuticals, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amneal Pharmaceuticals,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 164.4 M, Interest Expense of 134.8 M or Selling General Administrative of 303.3 M, as well as many indicators such as Price To Sales Ratio of 0.83, Dividend Yield of 0.096 or Days Sales Outstanding of 132. Amneal financial statements analysis is a perfect complement when working with Amneal Pharmaceuticals, Valuation or Volatility modules.
Amneal | Begin Period Cash Flow |
Latest Amneal Pharmaceuticals,'s Begin Period Cash Flow Growth Pattern
Below is the plot of the Begin Period Cash Flow of Amneal Pharmaceuticals, Class over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. Amneal Pharmaceuticals,'s Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amneal Pharmaceuticals,'s overall financial position and show how it may be relating to other accounts over time.
| Begin Period Cash Flow | 10 Years Trend |
|
Begin Period Cash Flow |
| Timeline |
Amneal Begin Period Cash Flow Regression Statistics
| Arithmetic Mean | 122,893,350 | |
| Geometric Mean | 101,540,824 | |
| Coefficient Of Variation | 69.14 | |
| Mean Deviation | 63,746,481 | |
| Median | 81,885,000 | |
| Standard Deviation | 84,969,521 | |
| Sample Variance | 7219.8T | |
| Range | 311.9M | |
| R-Value | 0.40 | |
| Mean Square Error | 6512.7T | |
| R-Squared | 0.16 | |
| Significance | 0.13 | |
| Slope | 7,095,985 | |
| Total Sum of Squares | 108297.3T |
Amneal Begin Period Cash Flow History
About Amneal Pharmaceuticals, Financial Statements
Amneal Pharmaceuticals, investors use historical fundamental indicators, such as Amneal Pharmaceuticals,'s Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Amneal Pharmaceuticals,. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Begin Period Cash Flow | 99.1 M | 149 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Amneal Stock Analysis
When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.